Trial Profile
Maraviroc Enhancement of Immunological Response: A pilot study of maraviroc as an add-on in patients with reduced CD4 cell count despite full viral suppression
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Jan 2013
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms MENHIR
- 22 Mar 2012 New trial record